The coronavirus disease 2019 (COVID-19) pandemic overwhelmed the healthcare systems in many countries with large numbers of acutely ill patients. However, as months passed, chronic sequelae...
The RNF41 protein could be a new therapeutic target in the fight against two chronic liver diseases: cirrhosis and liver inflammation. This is stated in a...
In a recent study published in scientific reportresearchers investigated the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein subunit 1 (S1) on...
Airway mucus is less sticky and inflammation in the lungs is greatly reduced. The 3-in-1 combination provides sustained and sustained benefit in patients with cystic fibrosis...
In 2021, 365,000 people reportedly had breast implants in the United States.1 A recent study comparing the use of digital breast tomosynthesis (DBT) in women with...
In a recent article published in lancet, researchers focused on pulmonary and extrapulmonary sequelae to explain the heterogeneous nature of long-term coronavirus infection (Long-COVID).they investigated pre-existing...
Recent Comments